CH Biotech R&D Co., Ltd. (TPE:6534)
85.50
-3.50 (-3.93%)
Nov 6, 2026, 1:30 PM CST
| Market Cap | 8.62B -14.5% |
| Revenue (ttm) | 1.87B +11.3% |
| Net Income | 604.70M +66.0% |
| EPS | 5.88 +66.6% |
| Shares Out | 100.80M |
| PE Ratio | 14.54 |
| Forward PE | n/a |
| Dividend | 5.31 (6.21%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 136,314 |
| Open | 80.10 |
| Previous Close | 89.00 |
| Day's Range | 80.10 - 89.40 |
| 52-Week Range | 77.60 - 104.00 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |